10 ML naxitamab-gqgk 4 MG/ML Injection [Danyelza]
RxNorm concept 2474244, branded drug (sbd). Prescribable name: DANYELZA 40 MG in 10 ML Injection.
- RxCUI
- 2474244
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2474244 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
10 ML Danyelza 4 MG/ML Injection; Danyelza 40 MG per 10 ML Injection
Related concepts
- naxitamab-gqgk 4 MG/ML (SCDC, consists of)
- naxitamab-gqgk 4 MG/ML [Danyelza] (SBDC, consists of)
- Injection (DF, has dose form)
- Danyelza (BN, has ingredient)
- 10 ML naxitamab-gqgk 4 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
- 50633023001
- 73042020101
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2474244 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2474244 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2474244. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.